CrossrefInfokarte
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)
DOI: 10.1007/s00280-024-04731-y ↗Abstract
Kein Abstract verfügbar.
EUVIMED